# The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults

> **NCT02225600** · NA · SUSPENDED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 40 (estimated)

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DRUG:** 40 IU Intranasal Oxytocin
- **DRUG:** Placebo
- **DRUG:** 24 IU intranasal Oxytocin

## Key facts

- **NCT ID:** NCT02225600
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2014-08-26
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Avoiding intranasal spray durng COVID
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02225600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02225600, "The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02225600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*